Pieters R - Search Results

1

Integrative analysis of type-I and type-II aberrations underscores the genetic heterogeneity of pediatric acute myeloid leukemia.

Balgobind BV, Hollink IH, Arentsen-Peters ST, Zimmermann M, Harbott J, Beverloo HB, von Bergh AR, Cloos J, Kaspers GJ, de Haas V, Zemanova Z, Stary J, Cayuela JM, Baruchel A, Creutzig U, Reinhardt D, Pieters R, Zwaan CM, van den Heuvel-Eibrink MM. Balgobind BV, et al. Among authors: pieters r. Haematologica. 2011 Oct;96(10):1478-87. doi: 10.3324/haematol.2010.038976. Epub 2011 Jul 26. Haematologica. 2011. PMID: 21791472 Free PMC article.

2

In vitro drug sensitivity of normal peripheral blood lymphocytes and childhood leukaemic cells from bone marrow and peripheral blood.

Kaspers GJ, Pieters R, Van Zantwijk CH, De Laat PA, De Waal FC, Van Wering ER, Veerman AJ. Kaspers GJ, et al. Among authors: pieters r. Br J Cancer. 1991 Sep;64(3):469-74. doi: 10.1038/bjc.1991.333. Br J Cancer. 1991. PMID: 1911186 Free PMC article.

3

In vitro chemosensitivity assessed with the MTT assay in childhood acute non-lymphoblastic leukemia.

Klumper E, Pieters R, Kaspers GJ, Huismans DR, Loonen AH, Rottier MM, van Wering ER, van der Does-van den Berg A, Hählen K, Creutzig U, et al. Klumper E, et al. Among authors: pieters r. Leukemia. 1995 Nov;9(11):1864-9. Leukemia. 1995. PMID: 7475276

4

Topoisomerase II alpha gene expression in childhood acute lymphoblastic leukemia.

Klumper E, Giaccone G, Pieters R, Broekema G, van Ark-Otte J, van Wering ER, Kaspers GJ, Veerman AJ. Klumper E, et al. Among authors: pieters r. Leukemia. 1995 Oct;9(10):1653-60. Leukemia. 1995. PMID: 7564505

5

In vitro cellular drug resistance in children with relapsed/refractory acute lymphoblastic leukemia.

Klumper E, Pieters R, Veerman AJ, Huismans DR, Loonen AH, Hählen K, Kaspers GJ, van Wering ER, Hartmann R, Henze G. Klumper E, et al. Among authors: pieters r. Blood. 1995 Nov 15;86(10):3861-8. Blood. 1995. PMID: 7579354 Free article.

6

Drug combination testing in acute lymphoblastic leukemia using the MTT assay.

Kaspers GJ, Veerman AJ, Pieters R, Van Zantwijk I, Hählen K, Van Wering ER. Kaspers GJ, et al. Among authors: pieters r. Leuk Res. 1995 Mar;19(3):175-81. doi: 10.1016/0145-2126(94)00126-u. Leuk Res. 1995. PMID: 7700079

7

Favorable prognosis of hyperdiploid common acute lymphoblastic leukemia may be explained by sensitivity to antimetabolites and other drugs: results of an in vitro study.

Kaspers GJ, Smets LA, Pieters R, Van Zantwijk CH, Van Wering ER, Veerman AJ. Kaspers GJ, et al. Among authors: pieters r. Blood. 1995 Feb 1;85(3):751-6. Blood. 1995. PMID: 7833478 Free article.

8

Different cellular drug resistance profiles in childhood lymphoblastic and non-lymphoblastic leukemia: a preliminary report.

Kaspers GJ, Kardos G, Pieters R, Van Zantwijk CH, Klumper E, Hählen K, de Waal FC, van Wering ER, Veerman AJ. Kaspers GJ, et al. Among authors: pieters r. Leukemia. 1994 Jul;8(7):1224-9. Leukemia. 1994. PMID: 8035616

9

Glucocorticoid resistance in childhood leukemia.

Kaspers GJ, Pieters R, Klumper E, De Waal FC, Veerman AJ. Kaspers GJ, et al. Among authors: pieters r. Leuk Lymphoma. 1994 Apr;13(3-4):187-201. doi: 10.3109/10428199409056282. Leuk Lymphoma. 1994. PMID: 8049644 Review.

10

Cellular drug resistance in childhood leukemia.

Veerman AJ, Kaspers GJ, Pieters R. Veerman AJ, et al. Among authors: pieters r. Ann Hematol. 1994;69 Suppl 1:S31-4. doi: 10.1007/BF01757352. Ann Hematol. 1994. PMID: 8061109 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

997 results

Search Page